SCNI: Scinai Immunotherapeutics Ltd Kompaniya qiymatining sof foydaga nisbati

BiondVax Pharmaceuticals - SCNI emitenti grafik logotipi

Scinai Immunotherapeutics (SCNI) immunologlardan iborat jipslashtirilgan xodimlar jamoasiga tayanadi va strategik ravishda klinik sinovlar mutaxassislarini jalb qilmoqda. Biznesning innovatsion poydevori pandemiya tahdidlariga qarshi himoya vositalarini tezkor yaratish uchun mo‘ljallangan nanotana platformasidir. -0.20 metrikasi aks etgan ushbu narx harakati grafigi kompaniyaning bozor kontekstini namoyish etadi. Isroil ishlab chiquvchisi moslashuvchan R&D yondashuvini qo‘llaydi, bu esa barqaror laboratoriya bazasini saqlagan holda yangi viruslar uchun formulalarning tezlashtirilgan adaptatsiyasini ta’minlaydi.

Scinai Immunotherapeutics Ltd. (SCNI) Narxning foydaga nisbati: 18.05.2024 - 17.11.2026 davri uchun

BiondVax Pharmaceuticals (SCNI) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Scinai Immunotherapeutics Ltd. SCNI
Scinai brend mahsuloti

Scinai Immunotherapeutics (SCNI) investorlari uchun biznesning bozor qiymatini uning haqiqiy foyda keltirish qobiliyati bilan solishtirish juda muhimdir. Ushbu metrika bozor kapitalizatsiyasining sof foydaga nisbatini o'lchab, aktivning haddan tashqari qimmat yoki arzon baholanganligini aniqlaydi. Kompaniyaning tarixiy o'rtacha P/E ko'rsatkichini tahlil qilish orqali ekstremal xavf yoki foydali kirish nuqtalarini aniqlash mumkin. Ushbu Isroil biznesi uchun mazkur ko'rsatkich mintaqaviy beqarorlikka qarshi kapital barqarorligini aks ettiradi. Scinai Immunotherapeutics ning global sherikliklari grafikdagi tez-tez uchraydigan tebranishlarni yumshatib, kompaniyaning fundamental qiymatini tasdiqlaydi.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics, Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Bio|Narxning foydaga nisbati Theratechnologies, Inc.|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics AVTX|P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|adagene.com (ADAG) - Narx-foyda koeffitsiyenti|Ikena Oncology (IMA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Shattuck Labs, Inc.|Narxning foydaga nisbati equilliumbio.com|Narx-foyda koeffitsiyenti connectbiopharm.com (CNTB)|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati Atara Bio|Narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Narxning foydaga nisbati|ACET: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CELU (celularity.com)|INMB: P/E multiplikatori|BRNS: Bozor narxining sof foydaga nisbati|KZR (Kezar Life Sciences, Inc.) - P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori AKTX|Narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Narx-foyda koeffitsiyenti|EDSA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati iBio|CARM: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Narxning foydaga nisbati boltbio.com|P/E multiplikatori HCW Biologics|P/E multiplikatori APVO|AIM - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ADTX (Aditxt Inc.)|Biznesning o‘zini qoplash muddati GRI Bio, Inc. (GRI)|XRTX - Narxning foydaga nisbati|reshapelifesciences.com (HIND) - Narx-foyda koeffitsiyenti|REVB: P/E multiplikatori|Indaptus Therapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori